Bookbuilding IPO | ₹15 Cr | Listed at NSE SME | Mon, Aug 28, 2023 - Wed, Aug 30, 2023
Mono Pharmacare IPO is a book build issue of ₹14.84 crores. The issue is entirely a fresh issue of 0.53 crore shares of ₹14.84 crore.
Mono Pharmacare IPO bidding started from Aug 28, 2023 and ended on Aug 30, 2023. The allotment for Mono Pharmacare IPO was finalized on Sep 4, 2023. The shares got listed on NSE SME on Sep 7, 2023.
Mono Pharmacare IPO price band is set at ₹28 per share. The lot size for an application is 4,000. The minimum amount of investment required by an retail is ₹1,12,000 (4000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (8,000 shares), amounting to ₹2,24,000.
Unistone Capital Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Rikhav Securities Ltd..
Refer to Mono Pharmacare IPO RHP for detailed Information.
IPO Open
Mon, Aug 28, 2023
IPO Close
Wed, Aug 30, 2023
Issue Price
₹28 per share
Market Cap (Pre-IPO)
₹49.47 Cr
| IPO Date | 28 to 30 Aug, 2023 |
| Listed on | Thu, Sep 7, 2023 |
| Face Value | ₹10 per share |
| Price Band | ₹26 to ₹28 |
| Issue Price | ₹28 per share |
| Lot Size | 4,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 53,00,000 shares (agg. up to ₹15 Cr) |
| Reserved for Market Maker | 2,76,000 shares Rikhav Securities Ltd. (agg. up to ₹0.7728 Cr) |
| Fresh Issue (Ex Market Maker) | 50,24,000 shares (agg. up to ₹14 Cr) |
| Net Offered to Public | 50,24,000 shares (agg. up to ₹14 Cr) |
| Share Holding Pre Issue | 1,23,68,564 shares |
| Share Holding Post Issue | 1,76,68,564 shares |
| NSE Symbol | MONOPHARMA |
| ISIN | INE0OIP01012 |
Mono Pharmacare IPO comprises a total issue size of 53,00,000 shares. The net offer to the public is 50,24,000 shares, after excluding 2,76,000 shares allotted on a firm basis. Of the Net offer 5,00,000 (9.95%) are allocated to QIB, 22,60,000 (44.98%) allocated to NII 22,64,000 (45.06%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| QIB Shares Offered | 5,00,000 | 9.95% | 9.43% |
| NII (HNI) Shares Offered | 22,60,000 | 44.98% | 42.64% |
| Retail Shares Offered | 22,64,000 | 45.06% | 42.72% |
| Firm Reservations | |||
| Market Maker Shares Offered | 2,76,000 | 5.21% | |
| Total Shares Offered | 53,00,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 4,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4,000 | ₹1,12,000 |
| Retail (Max) | 1 | 4,000 | ₹1,12,000 |
| HNI (Min) | 2 | 8,000 | ₹2,24,000 |
Incorporated in 1994, Mono Pharmacare Limited is engaged in the business of marketing and distribution of pharmaceutical products.
The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac - Diabetic medicines, and cosmocare products.
Mono Pharmacare works with contract manufacturers to manufacture pharmaceutical products to sell them under their brand name DLS Export. The company acquired DLS Export in 2022, for an aggregate consideration of ₹ 609 lakhs, in order to grow its product portfolio in selected therapeutic areas.
As on February 28, 2023, the company has over 168 pharmaceutical companies as their distributors and stockists and also, and served over 3,036 customers/vendors who are a mix of retail pharmacy stores as well as wholesalers.
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|
| Assets | 62.57 | 14.38 | 11.22 | 8.72 |
| Total Income | 37.10 | 28.38 | 11.69 | |
| Profit After Tax | 0.35 | 0.10 | 0.02 | |
| NET Worth | 4.28 | 3.70 | 2.02 | |
| Reserves and Surplus | 1.32 | |||
| Total Borrowing | 6.44 | 6.08 | 6.33 | |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To meet the working capital requirements | 8.98 |
| 2 | General corporate purposes; and | 3.66 |
| KPI | |
|---|---|
| ROE | 9.01% |
| ROCE | 10.34% |
| Debt/Equity | 2.92 |
| RoNW | 9.01% |
| PAT Margin | 2.11% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 1.99 | |
| P/E (x) | 40 | |
| Promoter Holding | 81.02% | |
| Market Cap | ₹49.47 Cr. |
The Mono Pharmacare IPO is subscribed 13.42 times on August 30, 2023 7:19:00 PM (Day 3). The public issue subscribed 19.4 times in the retail category, 10.89 times in the QIB category, and 8 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 10.89 | 5,00,000 | 54,44,000 |
| NII* | 8 | 22,60,000 | 1,80,72,000 |
| Retail | 19.4 | 22,64,000 | 4,39,12,000 |
| Total | 13.42 | 50,24,000 | 6,74,28,000 |
Total Application : 10,978
*Market Maker portion is not included to NII/HNI.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Issue relating expenses such as fees to Book Running Lead manager Fixed Fee, Registrar to the Issue, Legal Advisors, Auditors, statutory advertisements and other expenses incurred / to be incurred including promotional expenses | 0.61 |
| 2 | Underwriting commission, brokerage and selling commission (including Commission/ processing fees for SCSBs, Sponsor Bank, Members of the Syndicate, Registered Brokers, RTAs and CDPs | 1.49 |
| 3 | Listing fees, Stock Exchange processing/ listing fees, software fees, Depositories’ fees, other regulatory expenses and sundry expenses | 0.10 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹28.00 |
| Open | ₹29.00 |
| Low | ₹29.00 |
| High | ₹30.45 |
| Last Trade | ₹30.45 |
Lead Manager Reports
Mono Pharmacare IPO is a SME IPO of 53,00,000 equity shares of the face value of ₹10 aggregating up to ₹15 Crores. The issue is priced at ₹28 per share. The minimum order quantity is 4000.
The IPO opens on Mon, Aug 28, 2023, and closes on Wed, Aug 30, 2023.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Mono Pharmacare IPO using UPI as a payment gateway. Zerodha customers can apply in Mono Pharmacare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Mono Pharmacare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Mono Pharmacare IPO opens on Mon, Aug 28, 2023 and closes on Wed, Aug 30, 2023.
Mono Pharmacare IPO lot size is 4000, and the minimum amount required for application is ₹1,12,000.
You can apply in Mono Pharmacare IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Mono Pharmacare IPO will be done on Monday, September 4, 2023, and the allotted shares will be credited to your demat account by Wed, Sep 6, 2023. Check the Mono Pharmacare IPO allotment status.
The Mono Pharmacare IPO listing date is on Thu, Sep 7, 2023.
